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Abstract 
Introduction: Post-infectious encephalitis/encephalopathy is a neurological syndrome that sometimes develops 
following common viral or bacterial infections. The most common form is acute disseminated encephalomyelitis 
(ADEM). ADEM is a demyelinating disease of the central nervous system that typically presents as a monophasic 
disorder associated with multifocal neurologic symptoms and encephalitis. Anti-N-methyl-d-aspartate receptor (anti-
NMDAR) encephalitis is another type of severe autoimmune disorder, characterized by seizures, movement disor-
ders and psychiatric symptoms. In general, the prognosis and long-term outcomes of both ADEM and anti-NMDAR 
encephalitis are favorable. Most patients show complete, albeit slow recovery over a period of one to 2 years. There 
are few reports of patients with these disorders showing long-term residual psychiatric symptoms.
Case presentation: We report the case of a 16-year-old Japanese male who suffered from acute post-infectious 
encephalitis. The patient followed an atypical recovery course, in that he showed poor rapport, lack of spontaneity 
and passive social withdrawal for more than 2 years after the initial symptoms. While treatment with small doses of 
antipsychotic drugs at the hospital had no effect on the symptoms, the patient recovered gradually over a prolonged 
period of five or so years.
Conclusions: This case report suggests that a type of acute post-infectious encephalitis with demyelinating features, 
possibly ADEM or anti-NMDAR encephalitis, or an overlap between the two, can cause a prodrome of behavioral 
changes and long-term residual psychiatric symptoms for many months, although it is eventually associated with a 
good prognosis.
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Introduction
Post-infectious encephalitis is a neurological syndrome 
that is known to sometimes develop after common 
viral or bacterial infections. The most common form is 
acute disseminated encephalomyelitis (ADEM), which 
is a demyelinating disease of the central nervous system 
(CNS) that typically presents as a monophasic disorder 
associated with multifocal neurologic symptoms and 
encephalitis. ADEM is considered as an autoimmune 
disorder. The diagnosis is usually based on the clinical 
and radiologic features. Lumbar puncture and labora-
tory studies are useful, however, many children show 
only non-specific findings of inflammation. Magnetic 
resonance imaging (MRI) may show widespread, multi-
focal, asymmetric white- and gray-matter abnormalities, 
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often involving areas of the thalamus or the basal ganglia 
bilaterally (Menge et al. 2005; Mikaeloff et al. 2007; Gupte 
et  al. 2003; Hynson et  al. 2001; Lotze and Chadwick 
2011; Dale et  al. 2000). Abnormal lesions are typically 
bilateral, and can be clearly visualized on T2-weighted 
images and fluid-attenuated inversion recovery (FLAIR) 
images. The number and sizes of the lesions vary among 
patients. The differential diagnosis includes such con-
ditions as multiple sclerosis, optic neuritis, transverse 
myelitis, neuromyelitis optica, infectious meningoen-
cephalitis, anti-phospholipid antibody syndrome, iso-
lated CNS angiitis, vasculitis secondary to rheumatic 
autoimmune disease, CNS neoplasms, neurosarcoidosis, 
mitochondrial encephalopathies, and adrenoleukodys-
trophy (Lotze and Chadwick 2011; Menge et  al. 2005; 
Tenembaum et  al. 2007). The prognosis and long-term 
outcome of ADEM are favorable.
On the other hands, anti-N-methyl-d-aspartate recep-
tor (anti-NMDAR) encephalitis is another type of severe 
autoimmune disorder developing following common 
viral/bacterial infections, that is characterized by sei-
zures, movement disorders and psychiatric symptoms. 
Brain MRI in cases of anti-NMDAR encephalitis is fre-
quently normal or may reveal only subtle lesions, not 
usually restricted to the white matter. Patients with 
anti-NMDAR encephalitis may be diagnosed as hav-
ing different conditions at different stages of the disease. 
New-onset psychosis or viral encephalitis is an early 
presumptive diagnosis in some patients. Anti-NMDAR 
encephalitis patients often show spontaneous neurologi-
cal improvement, although the recovery can be incom-
plete or delayed. Some patients show social-behavioral 
abnormalities and impaired executive functions for many 
months (Dalmau et al. 2011).
Herein, we describe the atypical case of a 16-year-old 
male patient who was diagnosed as having acute post-
infectious encephalitis, and presented with psychiatric 
symptoms such as poor rapport, poor motivation and 
flattened affect that persisted for a long period of time 
after recovery from the initial symptoms.
Case presentation
The patient was a 16-year-old Japanese male, with a nor-
mal birth history and normal developmental milestones. 
He was a high-achieving pupil, with no family history of 
psychiatric disorders. He had received his last diphtheria/
pertussis/tetanus and measles vaccinations at the age of 
one and a half years, with no history of any significant 
health problems thereafter.
When he was 15 years old, the patient began to develop 
a defiant attitude towards his father. He often stayed up 
late using the Internet and his school grades began to 
deteriorate. There were no prodromal symptoms at that 
time. At the start of the present illness, the patient devel-
oped easy fatigability with throat and foot pain. It was 
thought that the symptoms were related to a cold, and he 
attended school after taking medicines for common cold. 
Ten days later, however, he stopped eating and respond-
ing to others. Thereafter, after 2 days, he developed fever 
and quivered convulsively, and his parents took him to a 
neighborhood hospital. MRI of the brain was performed, 
and the T2-weighted and FLAIR images revealed high-
intensity lesions in the subcortical white matter of the 
frontal lobes bilaterally, and in the left temporal lobe 
(Fig.  1a, b). These lesions on the T2 and FLAIR images 
could not be visualized on the T1 sequences. Cerebrospi-
nal fluid (CSF) examination revealed the following: cell 
count 66/mm3 (monocytes 43/mm3), protein 41.5 mg/dl, 
glucose 81 mg/dl. Based on a suspicion of viral encepha-
litis, the patient was started on an antiviral drug and ster-
oid pulse therapy. The second CSF examination revealed 
a cell count of 8/mm3 (monocytes 3/mm3), protein level 
of 25.9 mg/dl, negative results for oligoclonal bands and 
myelin basic protein, and normal levels of IgG and IgM. 
The patient’s level of consciousness improved the follow-
ing day, and with the resolution of all the other symptoms 
a week later, he was discharged. The following month, 
the patient gradually stopped going to school and began 
to stay at home. He also refused to go to the hospital. 
A month later, his family managed to bring him to the 
Neurology Department of our hospital. After the initial 
examination, the neurologist recommended hospitaliza-
tion for more detailed examination, however, the patient 
refused. The doctor then referred him to our psychiatry 
department.
When he attended his first appointment, he was on a 
wheelchair. He did not answer any questions, keeping his 
head low and his eyes shut. Assessment on the Glasgow 
Coma Scale revealed a score of 4 for eye opening, 4 for 
verbal response and 6 for motor response, and it was not 
clear why he was refusing to talk or engage in conversa-
tions. With his parents’ consent, we decided to hospital-
ize him for closer examination. He did not resist, but he 
continued to refuse to communicate with the hospital 
staff even after hospitalization. He had no paralysis, no 
finger tremors, or any neck stiffness. The muscle tone 
and reflexes could not be clearly assessed, because the 
patient’s refusal to cooperate. He could eat and take care 
of his personal activities of daily living, although he was 
unwilling to take a bath daily. Rheumatologic disease, 
such as CNS lupus or vasculitis, was excluded, because 
the serological tests for antinuclear antibody, Rh factor, 
antimitochondrial antibody, proteinase-3 anti-neutrophil 
cytoplasmic antibody (PR3-ANCA) and myeloperoxidase 
anti-neutrophil cytoplasmic antibody (MPO-ANCA) 
were negative. Other antibodies associated with some 
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other forms of autoimmune encephalitis, e.g. anti-
NMDAR and anti-voltage gated potassium channel 
antibodies, were not tested for. The same high-intensity 
lesions in the subcortical white matter as those seen a 
month earlier were still observed on the T2-weighted and 
FLAIR images on brain MRI (Fig. 2a, b).
After admission, the patient isolated himself in his 
room and refused to talk, not only to the medical staff, 
but also to his own family members. We could not assess 
whether he suffered from disorientation and speech 
impediment, although he took his meals regularly and 
slept well. The electroencephalogram showed neither 
Fig. 1  Magnetic resonance imaging (MRI) of the brain: a 
T2-weighted image. b fluid-attenuated inversion recovery (FLAIR) 
image
Fig. 2 Magnetic resonance imaging (MRI) of the brain after hospitali-
zation: a T2-weighted image. b Fluid-attenuated inversion recovery 
(FLAIR) image
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slow nor spike waves. We considered the possibility of 
disorganized schizophrenia, because of his disorgan-
ized behavior and speech, flat affect, and disturbance 
in behavior, communication and thought. We initiated 
treatment with risperidone, at a starting dose of 0.5 mg 
daily, which was gradually increased to 4  mg over a 
period of 4  weeks. Because there was no effect, how-
ever, we added aripiprazole at the dose of 6 mg daily for 
2 weeks, however, this also had no effect on the patient’s 
symptoms. One month after admission, the patient began 
to speak gradually, and demanded to leave the hospital. 
When we explained the need for further assessment of 
his health status, he agreed, and an intelligence assess-
ment, lumbar puncture, and single photon emission 
computed tomography (SPECT) were performed. SPECT 
showed slightly enhancing lesions in the anterior lobes, 
which were non-specific findings. CSF examination 
revealed the following findings: cell count 0/mm3, pro-
tein 18 mg/dl, glucose 64 mg/dl, IgG, IgA and IgM levels 
within normal limits. Examination by the Wechsler Intel-
ligence Scale for Children—Third Edition (WISC-III) 
showed an above-average Intelligence Quotient (IQ). The 
patient was discharged from the hospital, but still tended 
to stay at home and absent himself from school. Even 
when he tried to attend school, he could not persist with 
it. At home, he took care of his personal activities of daily 
living, but could not sleep regularly and often became 
depressed. We increased the dose of aripiprazole to 
12 mg daily and decreased the dose of risperidone to 3 mg 
for 2 weeks after discharge. We suggested continuing the 
antipsychotic drug treatment to him and his mother, but 
both disagreed and the treatment was stopped. Nine 
months later, he was unable to proceed to the next year 
of school and 2 years later, he quit high school. He was 
not sociable, and sometimes showed depressed mood. A 
repeat brain MRI at that point revealed no changes from 
the findings at the earlier imagings. However, thereafter, 
the patient gradually recovered, and about 2 years later, 
he passed the Certificate for Students Achieving the Pro-
ficiency Level of Upper Secondary School Graduates. 
During the entire course, the patient showed no evidence 
of auditory hallucinations, delusions or other symptoms 
suggestive of schizophrenia. Overall, his presentation 
remained stable during follow-up. The timeline is shown 
in Fig. 3.
Discussion
The diagnosis in this patient was first suspected as 
ADEM, because (1) the clinical symptoms, such as dis-
turbance of consciousness and convulsions, developing 
after the infectious symptoms were suggestive of acute 
encephalitis, (2) there were disseminated demyelinat-
ing lesions on head MRI, and (3) there were no signs 
suggestive of viral encephalitis, bacterial meningitis 
or other immunologic diseases such as CNS lupus or 
vasculitis.
The patient followed an atypical recovery course, in 
that he showed poor rapport, lack of spontaneity and 
passive social withdrawal for more than 2 years after the 
initial symptoms. He did not have any paralyses or other 
neurological symptoms, and his IQ was above average. 
The long-term clinical outcome in patients with ADEM is 
usually favorable. Most children show complete, although 
slow, recovery over a period of 1–6 months. According to 
previous reports, about 57–89 % of cases show full recov-
ery with few residual deficits (Hynson et al. 2001; Menge 
et  al. 2005; Nasr et  al. 2000; Lotze and Chadwick 2011; 
Tenembaum et al. 2007). However, there are also reports 
of cases not showing full recovery and manifesting resid-
ual symptoms. Such patients could show severe symp-
toms, such as hemiparesis, partial seizures, reduction of 
visual acuity, paraparesis, urinary retention, neuropathic 
bladder, dysphasia, behavioral problems or mental handi-
cap (Murthy et  al. 2002; Dale et  al. 2000; Tenembaum 
et  al. 2002). Moreover, subtle neurocognitive deficits in 
attention, executive function, behavioral changes and 
psychiatric disturbances and speech disturbance have 
been demonstrated, even after 3 years, in some children 
who were thought to have recovered fully (Suppiej et al. 
2014; Tenembaum et al. 2007; Hynson et al. 2001; Hahn 
et al. 2003). Onset of illness after 6 years of age has also 
been shown to be associated with decreased Intelligence 
Quotient scores in verbal processing (Jacobs et al. 2004). 
In our patient reported here, the findings of high signal 
intensity lesions on the T2-weighted and FLAIR images 
on head MRI remained unchanged even after the patient 
recovered from the clinical symptoms. His recovery 
course after acute post-infectious encephalitis was con-
sistent with that reported for cases of ADEM.
This patient had some atypical features of ADEM: (1) 
the high signal intensity lesions on MRI were smaller 
than the typical lesions of ADEM; (2) the imaging find-
ings did not improve with convalescence; (3) the patient 
did not have a polysymptomatic presentation. Thus, 
the possibility of another type of acute post-infectious 
encephalitis cannot be excluded. Autoimmune encepha-
litis cannot be excluded because tests for antibodies 
such as anti-NMDAR and anti-voltage gated potassium 
channel antibodies were not performed. This patient 
showed behavioral changes, psychiatric disturbances 
and might have even had speech disturbance, which 
suggest the possibility of anti-NMDAR encephalitis. It 
has now been reported that patients with anti-NMDAR 
encephalitis may develop demyelinating features as con-
current or independent episodes and in some cases, 
anti-NMDAR encephalitis has been diagnosed after 
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ADEM. Anti-NMDAR encephalitis is frequently associ-
ated with a normal brain MRI, despite its clinical sever-
ity, which remains a clinico-radiologic paradox. Patients 
with this condition often show psychiatric symptoms at 
the onset (Dalmau et al. 2011; Sartori et al. 2015). If left 
untreated, patients typically recover spontaneously after 
many years. Patients suffering from demyelinating disor-
ders with prominent psychiatric manifestations may have 
NMDAR encephalitis (Titulaer et al. 2014; Hacohen et al. 
2014). There is a possibility that our patient suffered from 
anti-NMDAR encephalitis which caused the prodrome 
of rebellious behavior and residual psychiatric illness. 
Moreover, this patient might have suffered from cata-
tonia, which is a feature of anti-NMDAR encephalitis, 
during his last hospitalization. In these cases, antibody 
studies are necessary to confirm the diagnosis of anti-
NMDAR encephalitis, but it is difficult to distinguish 
between ADEM and anti-NMDAR encephalitis, and the 
two conditions may overlap. The frequencies of these dis-
orders are not yet known (Titulaer et  al. 2014). Finally, 
we hypothesized that the entire course of the disease in 
our patient, including the prodrome of rebellious behav-
ior, the acute encephalitis and the residual psychiatric 
syndrome, was consistent with the diagnosis of ADEM 
Fig. 3 Timeline of interventions and outcomes. ADEM: acute disseminated encephalomyelitis
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or anti-NMDAR encephalitis, or an overlap between the 
two conditions.
The strength of this report lies in that we could exam-
ine the patient closely, could assess his psychiatric symp-
toms during hospitalization, and also follow the patient 
up for a prolonged period of time after he was discharged 
from the hospital. However, there were some limitations. 
First, the diagnosis of the acute post-infectious encepha-
litis could not be definitively established, because test-
ing for other autoimmune encephalitides, especially 
NMDAR encephalitis, were not undertaken. Second, the 
neurological data and clinical information were not suf-
ficient and remained unclear, because the patient was 
treated at another hospital during the acute phases. Fur-
thermore, case studies of various acute post-infectious 
encephalitides are warranted.
Conclusions
Our patient reported here suffered from acute post-
infectious encephalitis and showed an atypical recovery 
course, manifesting psychiatric symptoms, including 
poor rapport, lack of spontaneity and passive social 
withdrawal for a period of over 2  years after the initial 
symptoms. There were no significant neurological mani-
festations such as paralysis, epilepsy or visual impair-
ment, and the patient eventually showed a good outcome. 
We hypothesized that the entire clinical course was con-
sistent with the diagnosis of ADEM or anti-NMDAR 
encephalitis, or an overlap between the two conditions.
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